Author： Mulder Douwe Haelst Paul Wobbes Martgriet Gans Rijk Zijlstra Felix May Johan Smit Andries Tervaert Jan Doormaal Jasper
Publisher： Springer Publishing Company
ISSN： 0920-3206
Source： Cardiovascular Drugs and Therapy, Vol.21, Iss.2, 2007-04, pp. : 91-97
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Previous Menu Next
Abstract
Related content
Lipid-lowering therapy in diabetes
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 342, 2001-01 ,pp. :
Access to resources
Recommend
National guidelines for lipid-lowering therapy unsatisfactory
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 348, 2002-01 ,pp. :
Colesevelam valuable adjunct in lipid-lowering therapy
Inpharma, Vol. 1, Iss. 1285, 2001-01 ,pp. :
Consider lipid-lowering therapy for patients with diabetes and hyperlipidaemia
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 283, 2000-01 ,pp. :
Lipid-lowering therapy beneficial in the perioperative period
Inpharma, Vol. 1, Iss. 1437, 2004-01 ,pp. :